Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination.

Trunk, Andrew D; Shewan, Samuel K; Lee, Catherine J; Parker, Charles J; Couriel, Daniel R

Trunk, Andrew D; Shewan, Samuel K; Lee, Catherine J; Parker, Charles J; Couriel, Daniel R.

Trunk AD; The University of Utah Transplant and Cellular Therapy Program, Salt Lake City, UT, USA.
Shewan SK; Division of Hematology and Hematologic Maligancies, University of Utah School of Medicine, Salt Lake City, UT, USA.
Lee CJ; The University of Utah Transplant and Cellular Therapy Program, Salt Lake City, UT, USA.
Parker CJ; Division of Hematology and Hematologic Maligancies, University of Utah School of Medicine, Salt Lake City, UT, USA.
Couriel DR; The University of Utah Transplant and Cellular Therapy Program, Salt Lake City, UT, USA. daniel.couriel@hci.utah.edu.

Bone Marrow Transplant ; 57(3): 502-503, 2022 03.

Article in English | MEDLINE | ID: covidwho-1621227

Subject(s)

COVID-19; Graft vs Host Disease; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Graft vs Host Disease/etiology; Humans; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Graft vs Host Disease Topics: Vaccines Limits: Humans Language: English Journal: Bone Marrow Transplant Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: S41409-021-01543-z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google